Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeoMero-2: Meropenem PK and Safety in Infants with Meningitis
NCT01554124Phase 2Completed
- Sponsor
- Penta Foundation
- Start
- Feb 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of meropenem in bacterial meningitis, sponsored by Penta Foundation. Started Feb 2013; status: completed.
02
Drugs
meropenem
03
Conditions
bacterial meningitis
Beyond the preview
Go deeper on NCT01554124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01554124.